(Translated by
https://www.hiragana.jp/
)
KEGG T01003: 50689
Rattus norvegicus (rat): 50689
Help
Entry
50689 CDS
T01003
Symbol
Mapk3
Name
(RefSeq) mitogen-activated protein kinase 3
KO
K04371
mitogen-activated protein kinase 1/3 [EC:
2.7.11.24
]
Organism
rno
Rattus norvegicus (rat)
Pathway
rno01521
EGFR tyrosine kinase inhibitor resistance
rno01522
Endocrine resistance
rno01524
Platinum drug resistance
rno04010
MAPK signaling pathway
rno04012
ErbB signaling pathway
rno04014
Ras signaling pathway
rno04015
Rap1 signaling pathway
rno04022
cGMP-PKG signaling pathway
rno04024
cAMP signaling pathway
rno04062
Chemokine signaling pathway
rno04066
HIF-1 signaling pathway
rno04068
FoxO signaling pathway
rno04071
Sphingolipid signaling pathway
rno04072
Phospholipase D signaling pathway
rno04114
Oocyte meiosis
rno04140
Autophagy - animal
rno04148
Efferocytosis
rno04150
mTOR signaling pathway
rno04151
PI3K-Akt signaling pathway
rno04210
Apoptosis
rno04218
Cellular senescence
rno04261
Adrenergic signaling in cardiomyocytes
rno04270
Vascular smooth muscle contraction
rno04350
TGF-beta signaling pathway
rno04360
Axon guidance
rno04370
VEGF signaling pathway
rno04371
Apelin signaling pathway
rno04380
Osteoclast differentiation
rno04510
Focal adhesion
rno04520
Adherens junction
rno04540
Gap junction
rno04550
Signaling pathways regulating pluripotency of stem cells
rno04611
Platelet activation
rno04613
Neutrophil extracellular trap formation
rno04620
Toll-like receptor signaling pathway
rno04621
NOD-like receptor signaling pathway
rno04625
C-type lectin receptor signaling pathway
rno04650
Natural killer cell mediated cytotoxicity
rno04657
IL-17 signaling pathway
rno04658
Th1 and Th2 cell differentiation
rno04659
Th17 cell differentiation
rno04660
T cell receptor signaling pathway
rno04662
B cell receptor signaling pathway
rno04664
Fc epsilon RI signaling pathway
rno04666
Fc gamma R-mediated phagocytosis
rno04668
TNF signaling pathway
rno04713
Circadian entrainment
rno04720
Long-term potentiation
rno04722
Neurotrophin signaling pathway
rno04723
Retrograde endocannabinoid signaling
rno04724
Glutamatergic synapse
rno04725
Cholinergic synapse
rno04726
Serotonergic synapse
rno04730
Long-term depression
rno04810
Regulation of actin cytoskeleton
rno04910
Insulin signaling pathway
rno04912
GnRH signaling pathway
rno04914
Progesterone-mediated oocyte maturation
rno04915
Estrogen signaling pathway
rno04916
Melanogenesis
rno04917
Prolactin signaling pathway
rno04919
Thyroid hormone signaling pathway
rno04921
Oxytocin signaling pathway
rno04926
Relaxin signaling pathway
rno04928
Parathyroid hormone synthesis, secretion and action
rno04929
GnRH secretion
rno04930
Type II diabetes mellitus
rno04933
AGE-RAGE signaling pathway in diabetic complications
rno04934
Cushing syndrome
rno04935
Growth hormone synthesis, secretion and action
rno04960
Aldosterone-regulated sodium reabsorption
rno05010
Alzheimer disease
rno05020
Prion disease
rno05022
Pathways of neurodegeneration - multiple diseases
rno05034
Alcoholism
rno05132
Salmonella infection
rno05133
Pertussis
rno05135
Yersinia infection
rno05140
Leishmaniasis
rno05142
Chagas disease
rno05145
Toxoplasmosis
rno05152
Tuberculosis
rno05160
Hepatitis C
rno05161
Hepatitis B
rno05163
Human cytomegalovirus infection
rno05164
Influenza A
rno05165
Human papillomavirus infection
rno05166
Human T-cell leukemia virus 1 infection
rno05167
Kaposi sarcoma-associated herpesvirus infection
rno05170
Human immunodeficiency virus 1 infection
rno05171
Coronavirus disease - COVID-19
rno05200
Pathways in cancer
rno05203
Viral carcinogenesis
rno05205
Proteoglycans in cancer
rno05206
MicroRNAs in cancer
rno05207
Chemical carcinogenesis - receptor activation
rno05208
Chemical carcinogenesis - reactive oxygen species
rno05210
Colorectal cancer
rno05211
Renal cell carcinoma
rno05212
Pancreatic cancer
rno05213
Endometrial cancer
rno05214
Glioma
rno05215
Prostate cancer
rno05216
Thyroid cancer
rno05218
Melanoma
rno05219
Bladder cancer
rno05220
Chronic myeloid leukemia
rno05221
Acute myeloid leukemia
rno05223
Non-small cell lung cancer
rno05224
Breast cancer
rno05225
Hepatocellular carcinoma
rno05226
Gastric cancer
rno05230
Central carbon metabolism in cancer
rno05231
Choline metabolism in cancer
rno05235
PD-L1 expression and PD-1 checkpoint pathway in cancer
rno05417
Lipid and atherosclerosis
Brite
KEGG Orthology (KO) [BR:
rno00001
]
09130 Environmental Information Processing
09132 Signal transduction
04010 MAPK signaling pathway
50689 (Mapk3)
04012 ErbB signaling pathway
50689 (Mapk3)
04014 Ras signaling pathway
50689 (Mapk3)
04015 Rap1 signaling pathway
50689 (Mapk3)
04350 TGF-beta signaling pathway
50689 (Mapk3)
04370 VEGF signaling pathway
50689 (Mapk3)
04371 Apelin signaling pathway
50689 (Mapk3)
04668 TNF signaling pathway
50689 (Mapk3)
04066 HIF-1 signaling pathway
50689 (Mapk3)
04068 FoxO signaling pathway
50689 (Mapk3)
04072 Phospholipase D signaling pathway
50689 (Mapk3)
04071 Sphingolipid signaling pathway
50689 (Mapk3)
04024 cAMP signaling pathway
50689 (Mapk3)
04022 cGMP-PKG signaling pathway
50689 (Mapk3)
04151 PI3K-Akt signaling pathway
50689 (Mapk3)
04150 mTOR signaling pathway
50689 (Mapk3)
09140 Cellular Processes
09141 Transport and catabolism
04140 Autophagy - animal
50689 (Mapk3)
04148 Efferocytosis
50689 (Mapk3)
09143 Cell growth and death
04114 Oocyte meiosis
50689 (Mapk3)
04210 Apoptosis
50689 (Mapk3)
04218 Cellular senescence
50689 (Mapk3)
09144 Cellular community - eukaryotes
04510 Focal adhesion
50689 (Mapk3)
04520 Adherens junction
50689 (Mapk3)
04540 Gap junction
50689 (Mapk3)
04550 Signaling pathways regulating pluripotency of stem cells
50689 (Mapk3)
09142 Cell motility
04810 Regulation of actin cytoskeleton
50689 (Mapk3)
09150 Organismal Systems
09151 Immune system
04611 Platelet activation
50689 (Mapk3)
04613 Neutrophil extracellular trap formation
50689 (Mapk3)
04620 Toll-like receptor signaling pathway
50689 (Mapk3)
04621 NOD-like receptor signaling pathway
50689 (Mapk3)
04625 C-type lectin receptor signaling pathway
50689 (Mapk3)
04650 Natural killer cell mediated cytotoxicity
50689 (Mapk3)
04660 T cell receptor signaling pathway
50689 (Mapk3)
04658 Th1 and Th2 cell differentiation
50689 (Mapk3)
04659 Th17 cell differentiation
50689 (Mapk3)
04657 IL-17 signaling pathway
50689 (Mapk3)
04662 B cell receptor signaling pathway
50689 (Mapk3)
04664 Fc epsilon RI signaling pathway
50689 (Mapk3)
04666 Fc gamma R-mediated phagocytosis
50689 (Mapk3)
04062 Chemokine signaling pathway
50689 (Mapk3)
09152 Endocrine system
04910 Insulin signaling pathway
50689 (Mapk3)
04929 GnRH secretion
50689 (Mapk3)
04912 GnRH signaling pathway
50689 (Mapk3)
04915 Estrogen signaling pathway
50689 (Mapk3)
04914 Progesterone-mediated oocyte maturation
50689 (Mapk3)
04917 Prolactin signaling pathway
50689 (Mapk3)
04921 Oxytocin signaling pathway
50689 (Mapk3)
04926 Relaxin signaling pathway
50689 (Mapk3)
04935 Growth hormone synthesis, secretion and action
50689 (Mapk3)
04919 Thyroid hormone signaling pathway
50689 (Mapk3)
04928 Parathyroid hormone synthesis, secretion and action
50689 (Mapk3)
04916 Melanogenesis
50689 (Mapk3)
09153 Circulatory system
04261 Adrenergic signaling in cardiomyocytes
50689 (Mapk3)
04270 Vascular smooth muscle contraction
50689 (Mapk3)
09155 Excretory system
04960 Aldosterone-regulated sodium reabsorption
50689 (Mapk3)
09156 Nervous system
04724 Glutamatergic synapse
50689 (Mapk3)
04725 Cholinergic synapse
50689 (Mapk3)
04726 Serotonergic synapse
50689 (Mapk3)
04720 Long-term potentiation
50689 (Mapk3)
04730 Long-term depression
50689 (Mapk3)
04723 Retrograde endocannabinoid signaling
50689 (Mapk3)
04722 Neurotrophin signaling pathway
50689 (Mapk3)
09158 Development and regeneration
04360 Axon guidance
50689 (Mapk3)
04380 Osteoclast differentiation
50689 (Mapk3)
09159 Environmental adaptation
04713 Circadian entrainment
50689 (Mapk3)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
50689 (Mapk3)
05206 MicroRNAs in cancer
50689 (Mapk3)
05205 Proteoglycans in cancer
50689 (Mapk3)
05207 Chemical carcinogenesis - receptor activation
50689 (Mapk3)
05208 Chemical carcinogenesis - reactive oxygen species
50689 (Mapk3)
05203 Viral carcinogenesis
50689 (Mapk3)
05230 Central carbon metabolism in cancer
50689 (Mapk3)
05231 Choline metabolism in cancer
50689 (Mapk3)
05235 PD-L1 expression and PD-1 checkpoint pathway in cancer
50689 (Mapk3)
09162 Cancer: specific types
05210 Colorectal cancer
50689 (Mapk3)
05212 Pancreatic cancer
50689 (Mapk3)
05225 Hepatocellular carcinoma
50689 (Mapk3)
05226 Gastric cancer
50689 (Mapk3)
05214 Glioma
50689 (Mapk3)
05216 Thyroid cancer
50689 (Mapk3)
05221 Acute myeloid leukemia
50689 (Mapk3)
05220 Chronic myeloid leukemia
50689 (Mapk3)
05218 Melanoma
50689 (Mapk3)
05211 Renal cell carcinoma
50689 (Mapk3)
05219 Bladder cancer
50689 (Mapk3)
05215 Prostate cancer
50689 (Mapk3)
05213 Endometrial cancer
50689 (Mapk3)
05224 Breast cancer
50689 (Mapk3)
05223 Non-small cell lung cancer
50689 (Mapk3)
09172 Infectious disease: viral
05166 Human T-cell leukemia virus 1 infection
50689 (Mapk3)
05170 Human immunodeficiency virus 1 infection
50689 (Mapk3)
05161 Hepatitis B
50689 (Mapk3)
05160 Hepatitis C
50689 (Mapk3)
05171 Coronavirus disease - COVID-19
50689 (Mapk3)
05164 Influenza A
50689 (Mapk3)
05163 Human cytomegalovirus infection
50689 (Mapk3)
05167 Kaposi sarcoma-associated herpesvirus infection
50689 (Mapk3)
05165 Human papillomavirus infection
50689 (Mapk3)
09171 Infectious disease: bacterial
05132 Salmonella infection
50689 (Mapk3)
05135 Yersinia infection
50689 (Mapk3)
05133 Pertussis
50689 (Mapk3)
05152 Tuberculosis
50689 (Mapk3)
09174 Infectious disease: parasitic
05145 Toxoplasmosis
50689 (Mapk3)
05140 Leishmaniasis
50689 (Mapk3)
05142 Chagas disease
50689 (Mapk3)
09164 Neurodegenerative disease
05010 Alzheimer disease
50689 (Mapk3)
05020 Prion disease
50689 (Mapk3)
05022 Pathways of neurodegeneration - multiple diseases
50689 (Mapk3)
09165 Substance dependence
05034 Alcoholism
50689 (Mapk3)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
50689 (Mapk3)
09167 Endocrine and metabolic disease
04930 Type II diabetes mellitus
50689 (Mapk3)
04933 AGE-RAGE signaling pathway in diabetic complications
50689 (Mapk3)
04934 Cushing syndrome
50689 (Mapk3)
09176 Drug resistance: antineoplastic
01521 EGFR tyrosine kinase inhibitor resistance
50689 (Mapk3)
01524 Platinum drug resistance
50689 (Mapk3)
01522 Endocrine resistance
50689 (Mapk3)
09180 Brite Hierarchies
09181 Protein families: metabolism
01001 Protein kinases [BR:
rno01001
]
50689 (Mapk3)
09182 Protein families: genetic information processing
03036 Chromosome and associated proteins [BR:
rno03036
]
50689 (Mapk3)
09183 Protein families: signaling and cellular processes
04147 Exosome [BR:
rno04147
]
50689 (Mapk3)
Enzymes [BR:
rno01000
]
2. Transferases
2.7 Transferring phosphorus-containing groups
2.7.11 Protein-serine/threonine kinases
2.7.11.24 mitogen-activated protein kinase
50689 (Mapk3)
Protein kinases [BR:
rno01001
]
Serine/threonine kinases: CMGC group
MAPK family [OT]
50689 (Mapk3)
Chromosome and associated proteins [BR:
rno03036
]
Eukaryotic type
Centromeric chromatin formation proteins
SAC (spindle assembly checkpoint) factors
Protein kinases
50689 (Mapk3)
Exosome [BR:
rno04147
]
Exosomal proteins
Exosomal proteins of haemopoietic cells (B-cell, T-cell, DC-cell, reticulocyte, and mast cell)
50689 (Mapk3)
BRITE hierarchy
SSDB
Ortholog
Paralog
Gene cluster
GFIT
Motif
Pfam:
Pkinase
PK_Tyr_Ser-Thr
ABC1
APH
Haspin_kinase
Choline_kinase
FTA2
Kdo
Motif
Other DBs
NCBI-GeneID:
50689
NCBI-ProteinID:
NP_059043
RGD:
3046
Ensembl:
ENSRNOG00000053583
UniProt:
P21708
LinkDB
All DBs
Position
1:190797189..190803411
Genome browser
AA seq
380 aa
AA seq
DB search
MAAAAAAPGGGGGEPRGTAGVVPVVPGEVEVVKGQPFDVGPRYTQLQYIGEGAYGMVSSA
YDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVIGIRDILRAPTLEAMRDVY
IVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLINTTCD
LKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML
SNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINMKARNYLQSLPSKTKVAWAKLFPKS
DSKALDLLDRMLTFNPNKRITVEEALAHPYLEQYYDPTDEPVAEEPFTFDMELDDLPKER
LKELIFQETARFQPGAPEAP
NT seq
1143 nt
NT seq
+upstream
nt +downstream
nt
atggcggcggcggcggcggctccggggggcgggggcggggagcccaggggaactgctggg
gtcgtcccggtggtccccggggaggtggaggtggtgaaggggcagccattcgacgtgggc
ccacgctacacgcagctgcagtacatcggcgagggcgcgtacggcatggtcagctcagca
tatgaccacgtgcgcaagaccagagtggctatcaagaagatcagccccttcgagcatcaa
acctactgtcagcgcacgctgagagaaatccagatcttgctgcgattccgccatgagaat
gtcataggcatccgagacatcctcagagcacccaccctggaagccatgagagatgtttac
attgttcaggacctcatggagacggacctgtacaagctgctaaagagccagcagctgagc
aatgaccacatctgctacttcctctaccagatcctccggggcctcaagtacatacactcg
gccaatgtgctgcaccgggacctgaagccctccaatctgcttatcaacaccacctgcgac
cttaagatctgtgattttggccttgcccggattgctgaccctgagcacgaccacactggc
tttcttaccgagtatgtggccacacgctggtaccgagccccagagatcatgcttaactcc
aagggctacaccaaatccattgacatctggtctgtgggctgcattctggctgagatgctc
tccaaccggcctatcttccccggcaagcactacctggaccagctcaaccacattctaggt
atactgggttccccatcccaagaggacctaaattgtatcattaacatgaaggcccgaaac
tacctacagtctctgccctctaaaaccaaggtggcttgggccaagctttttcccaaatct
gactccaaagctcttgacctgctggaccggatgttaacctttaacccaaacaagcgcatc
acagtagaggaagcactggctcacccttacctggaacagtactatgatccgacagatgaa
ccagtggctgaggagccattcacctttgacatggagctggatgatctccccaaggagcgg
ctgaaggagctgatcttccaagagacagcccgcttccagccaggggcaccagaggccccc
taa
DBGET
integrated database retrieval system